SQZ - SQZ Biotechnologies GAAP EPS of -$2.76 beats by $0.34 revenue of $21.48M beats by $6.84M
2023-03-22 17:04:33 ET
- SQZ Biotechnologies press release ( NYSE: SQZ ): FY GAAP EPS of -$2.76 beats by $0.34 .
- Revenue of $21.48M (-20.7% Y/Y) beats by $6.84M .
- As of December 31, 2022, the Company had cash and cash equivalents of $63.7 million and anticipates this will be sufficient to fund operating expenses and capital expenditure requirements into 2024.
- Shares +45.91% AH.
For further details see:
SQZ Biotechnologies GAAP EPS of -$2.76 beats by $0.34, revenue of $21.48M beats by $6.84M